Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
28
NMPA:28
Drug Approvals
Nicardipine Hydrochloride Injection
- Product Name
- 盐酸尼卡地平注射液
- Approval Number
- 国药准字H20253423
- Approval Date
- Feb 20, 2025
NMPA
Betamethasone Sodium Phosphate Injection
- Product Name
- 倍他米松磷酸钠注射液
- Approval Number
- 国药准字H20253417
- Approval Date
- Feb 20, 2025
NMPA
Metoclopramide Hydrochloride Injection
- Product Name
- 盐酸甲氧氯普胺注射液
- Approval Number
- 国药准字H20253061
- Approval Date
- Jan 2, 2025
NMPA
Acetylcysteine Solution for Inhalation
- Product Name
- 吸入用乙酰半胱氨酸溶液
- Approval Number
- 国药准字H20249497
- Approval Date
- Dec 1, 2024
NMPA
Drotaverine Hydrochloride Injection
- Product Name
- 盐酸屈他维林注射液
- Approval Number
- 国药准字H20249323
- Approval Date
- Nov 15, 2024
NMPA
Lornoxicam for Injection
- Product Name
- 注射用氯诺昔康
- Approval Number
- 国药准字H20249091
- Approval Date
- Oct 16, 2024
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found